1152 Prostaglandin E1 Use in the Transfer of Infants With Suspected Duct Dependent Congenital Heart Disease

Archives of Disease in Childhood - United Kingdom
doi 10.1136/archdischild-2012-302724.1152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Side Effects of Therapy With Prostaglandin E1 in Infants With Critical Congenital Heart Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

Formation of Biologically Active 13,14-Dihydro-Prostaglandin E1 During Intravenous Infusion of Prostaglandin E1 in Newborns With Ductus Arteriosus-Dependent Congenital Heart Disease.

British Journal of Clinical Pharmacology
Pharmacology
1992English

Prostaglandin E1 Therapy in Patients of Congenital Heart Disease With Pulmonary Atresia

The KITAKANTO Medical Journal
1994English

Effects of Prostaglandin E1 Infusion in the Pre-Operative Management of Critical Congenital Heart Disease.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1985English

Sepsis in Young Infants With Congenital Heart Disease

Early Human Development
GynecologyChild HealthPediatricsPerinatologyObstetrics
2012English

Breastfeeding and Growth in Infants With Congenital Heart Disease

Journal of the Academy of Nutrition and Dietetics
MedicineNutritionFood ScienceDietetics
2019English

Gluten Sensitivity Among Egyptian Infants With Congenital Heart Disease

Open Access Macedonian Journal of Medical Sciences
Medicine
2017English

Scoring System for Periventricular Leukomalacia in Infants With Congenital Heart Disease

Pediatric Research
Child HealthPediatricsPerinatology
2015English

Onset of Brain Injury in Infants With Prenatally Diagnosed Congenital Heart Disease

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy